Skip to main content
LNTH logo

LNTH · Lantheus Holdings, Inc. · Metrics

Track LNTH — free
Market Cap
$6.67B
Shares
65.40M
Volume · Nov 18 946.87K Avg daily vol (3M) 1.04M

LNTH metrics

105 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$102.00
Market cap
$6.67B

Price action

23 metrics
Price change (1W)
+0.4%
Price change (30D)
+2.1%
Price change (3M)
+1.5%
Price change (6M)
+6.2%
Price change (YTD)
+53.3%
Price change (1Y)
+90.7%
Trailing year
Price change (5Y)
+252.2%
52-week high
$110.94
52-week low
$52.79
Change from 52-week high
-8.1%
Change from 52-week low
+93.2%
Annualized volatility
30.2%
Annualized volatility (3M)
4.2%
Implied volatility (30D)
10.8%
IV rank (1Y)
3.0
IV percentile (1Y)
3.4
Beta
0.5
RSI (14D)
67.9
Price vs SMA 50
+1.6%
Price vs SMA 200
+8.9%
Avg volume (3M)
1.04M
Relative volume
0.9
Average dollar volume
$104.16M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
65.40M

Valuation

12 metrics
P / E (TTM)
24.9
Trailing earnings · reciprocal yield 4.0%
PEG ratio
—
EV / revenue
4.2×
reciprocal yield 23.8%
EV / EBITDA
17.2×
reciprocal yield 5.8%
EV / EBIT
22.5×
reciprocal yield 4.4%
P / sales
4.3×
reciprocal yield 23.4%
P / book
4.9
reciprocal yield 20.3%
FCF yield
—
TTM · current market cap
Buyback yield
1.5%
P / FCF
—
P / operating cash flow
16.3
reciprocal yield 6.1%
Earnings yield
4.0%

Historical valuation

8 metrics
P / E historical average (3Y)
19.3×
reciprocal yield 5.2%
P / E historical average (5Y)
47.9×
reciprocal yield 2.1%
EV / revenue historical average (3Y)
3.6×
reciprocal yield 27.5%
EV / revenue historical average (5Y)
4.5×
reciprocal yield 22.0%
EV / EBIT historical average (3Y)
14.6×
reciprocal yield 6.9%
EV / EBIT historical average (5Y)
38.5×
reciprocal yield 2.6%
EV / EBITDA historical average (3Y)
12.1×
reciprocal yield 8.2%
EV / EBITDA historical average (5Y)
46.1×
reciprocal yield 2.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.5%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-05

Profitability

9 metrics
Gross margin
61.3%
Operating margin
18.6%
Trailing 12 months
Net margin
17.3%
Gross profit (TTM)
$957.06M
Operating profit (TTM)
$290.93M
Net income (TTM)
$269.90M
Trailing 12 months
Diluted EPS (TTM)
$4.10
FCF margin
—
Effective tax rate
21.2%

Per share

11 metrics
Revenue per diluted share (TTM)
$23.50
Gross profit per diluted share (TTM)
$14.39
Operating profit per diluted share (TTM)
$4.39
EBITDA per diluted share (TTM)
$5.76
Net income per diluted share (TTM)
$4.08
Operating cash flow per diluted share (TTM)
$6.16
Free cash flow per diluted share (TTM)
$3.71
Capital expenditures per diluted share (TTM)
$0.66
R&D per diluted share (TTM)
$3.26
Stock compensation per diluted share (TTM)
$1.13
Book value per share
$16.87

Growth

11 metrics
Revenue growth YoY
+1.5%
Year over year
Net income growth YoY
-19.4%
Revenue (TTM)
$1.56B
Trailing 12 months
EPS growth YoY
-19.5%
Shares change YoY
+1.1%
Year over year · more shares
Revenue CAGR (3Y)
+18.1%
Revenue CAGR (5Y)
+35.3%
EPS CAGR (3Y)
+104.3%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
19.9%
Return on assets
11.0%
Debt / equity
0.4
Current ratio
3.2
EBITDA (TTM)
$381.93M
Free cash flow (TTM)
—
Quick ratio
3.1
Interest coverage
14.7
Net debt / EBITDA
-0.3
Return on invested capital
18.4%
Trailing 12 months
Net cash
$111.87M
Latest balance sheet
Cash & equivalents
$683.61M
Total assets
$2.46B
Total debt
$571.74M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$409.48M
Capital expenditures (TTM)
—
R&D (TTM)
$217.82M
SG&A (TTM)
—
Stock compensation (TTM)
$75.47M
R&D / revenue
13.9%
Stock compensation / revenue
4.8%

Ownership (13F)

9 metrics
13F filers
431
13F filer change QoQ
-40
Institutional ownership
99.2%
Conviction holders (share of 13F filers)
2.3%
Crowding (high-turnover and private-fund holders)
35.5%
Private-fund adviser ownership
34.1%
Active holders' share change QoQ
-13.1%
Holder tenure
13.6
Price vs estimated holder cost
+13.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
23.8%

Short interest

3 metrics
Short interest
5.6%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
67 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1521036 CUSIP 516544103 13F (30d) 450 filings 402 filers Visit website Investor relations